Med spas rapidly are becoming the front door to healthcare, and Empower Aesthetics has put out the welcome mat. Partnering with financial sponsor Shore Capital, Empower’s platform of medical spas are located in Texas and Tennessee and building in the Midwest and upstate New York.
With McGuireWoods partner and host Geoff Cockrell,…
3 Boomerang Capital has announced a majority growth investment in Enjoin.
Enjoin, founded in 1988 and based in Collierville, Tennessee, provides clinical documentation integrity solutions for hospitals and health systems.
3 Boomerang, based in Greenwich, Conn., invests in lower middle market healthcare companies in North America and Western Europe. Founded in 2023, the…
Valeas Capital Partners has announced the closing of its first institutional fund at more than $600 million.
The inaugural fund, VCP Fund I, exceeded its target.
Valeas, founded in 2021 and based in San Francisco, is a middle-market, growth-buyout private equity firm. The firm prefers to invest between $50 million and $150 million in companies…
Argosy Healthcare Partners (AHP) has announced the recapitalization of Nicklas Medical Staffing (NMS).
NMS, founded in 2013 and based in Jacksonville, Florida, provides staffing solutions for pathology and histology labs.
AHP, based in Wayne, Pennsylvania, is a lower middle market private equity investor focused exclusively on healthcare. A division of Argosy Capital, AHP…
By Kevin Madagan
Ampersand Capital Partners has announced its acquisition of Nektar Therapeutics’ PEGylation reagent manufacturing business.
The business, which will be branded Gannet BioChem and continue to operate out of its facility in Huntsville, Alabama, develops, scales and manufactures polyethylene glycol (PEG) reagents, which are used in advanced biopharmaceutical and therapeutic products.
Frazier Healthcare Partners has announced the closing of a new fund with $2.3 billion of commitments.
The fund, Frazier Healthcare Growth Buyout Fund XI, was oversubscribed and hit its hard cap in six months. The fund will focus on acquiring controlling interests in middle-market healthcare companies.
Frazier, based in Seattle, is a provider of…
As the pharma services sector grows, regulators at the Department of Justice and Food and Drug Administration are putting everything from clinical trials to site management under the microscope.
McGuireWoods partner Clint Narver speaks from experience: He joined the firm after serving in leadership roles at both agencies. With host Geoff Cockrell, Clint helps…
At fast-growing Allied Digestive Health, with 194 gastrointestinal (GI) physicians, 75 nurse practitioners and locations throughout New Jersey and New York, COO Sap Sinha is excited about the future. “Private equity in general is looking at GI very specifically, and there are multiple reasons for it,” Sap says in this conversation with McGuireWoods…
Arlington Capital Partners has announced its acquisition of TEAM Technologies from Clearlake Capital Group.
TEAM Tech, founded in 1988 and based in Morristown, Tennessee, is a manufacturing solutions provider for medical and dental products.
Arlington Capital, founded in 1999 and based in Washington, D.C., is a private equity firm specializing in government-regulated industries,…
Shore Capital Partners has announced the recapitalization of Point C.
Point C, founded in 2020 and based in Chicago, is a third-party administrator of medical benefits, cost containment and other administrative services for self-insured employers.
Shore Capital, based in Chicago, pursues investments in the lower middle market in healthcare and several other industries.…
